Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death
worldwide. Prognosis and treatment options largely depend on tumor stage at diagnosis …

Hepatocellular carcinoma (HCC) is among the leading causes of cancer incidence and
mortality worldwide. Surveillance of individuals with cirrhosis or other conditions that confer …

Primary liver cancer is the sixth most common cancer in the world and the third cause of
cancer-related death. Hepatocellular carcinoma (HCC) represents more than 90% of …

Hepatocellular carcinoma (HCC) makes up 75%-85% of all primary liver cancers and is the
fourth most common cause of cancer related death worldwide. Chronic liver disease is the …

Background: Surveillance for hepatocellular carcinoma (HCC) is recommended in patients
with cirrhosis, but the effectiveness of a surveillance program in clinical practice has yet to …

The burden of hepatocellular carcinoma (HCC) is highest in East Asia and Africa, although
its incidence and mortality are rapidly rising in the United States and Europe. With the …

Hepatocellular carcinoma (HCC) is the seventh most common malignancy worldwide. HCC
meets all the criteria established by the World Health Organization for performing …

Background & Aims Ultrasound surveillance does not detect early stage hepatocellular
carcinomas (HCCs) in some patients with cirrhosis, although the reasons for this have not …

Major research efforts in liver cancer have been devoted to increasing the efficacy and
effectiveness of surveillance for hepatocellular carcinoma (HCC). As with other cancers …